Abstract
Trigeminal autonomic cephalalgias (TAC) pose a significant challenge for pain physicians. Despite being part of the primary headache disorders, they are uncommon in the general population. Although the literature commonly describes pharmacological management, in refractory patients, interventional pain modalities may be necessary .
Highlights
Trigeminal autonomic cephalalgias (TAC) pose a significant challenge for pain physicians
sphenopalatine ganglion (SPG) neuromodulation may be warranted 3. Such technology is unavailable in many countries
We would like to present this case of a 31-years-old female with a paroxysmal hemicrania (PH)/hemicrania continua (HC) refractory to medical management, including indomethacin 200 mg per day, gabapentin 2400 mg per day and tapentadol 600 mg per day
Summary
Trigeminal autonomic cephalalgias (TAC) pose a significant challenge for pain physicians. Carlos E Restrepo-Garces MD * 1, Sara Saldarriaga 2, Sergi Boada MD 3 *Corresponding Author: Carlos E Restrepo-Garces MD Address: Diagonal 75B N.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
